Incannex Healthcare (IXHL) filed a registration statement with the US Securities and Exchange Commission for the sale of 66 million shares by selling shareholders.
The prospectus covers 9.69 million shares of common stock held by the selling investors, 1.89 million shares issuable on the exercise of prefunded warrants, and 54.4 million shares issuable on the exercise of series A common stock warrants, the company said Monday in the regulatory filing.
The company won't receive any proceeds from the sale of shares, and any proceeds from the exercise of warrants will be used for working capital and general corporate purposes.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.